| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases (NCT04837885) | University Hospital, Bordeaux | 2021-09-24 |
| 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor (NCT05069220) | Peking Union Medical College Hospital | 2021-09-01 |
| Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®) (NCT05816720) | Novartis Pharmaceuticals | 2021-09-01 |
| Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients (NCT06570174) | Yonsei University | 2021-01-07 |
| Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (NCT04400474) | Grupo Espanol de Tumores Neuroendocrinos | 2020-10-07 |
| Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency (NCT04073017) | Vanderbilt-Ingram Cancer Center | 2019-11-04 |
| Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET (NCT03466216) | Orano Med LLC | 2018-02-05 |
| A Study of XmAb®18087 in Subjects With NET and GIST (NCT03411915) | Xencor, Inc. | 2018-01-22 |
| Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor (NCT03197012) | Thomas Hope | 2017-07-01 |
| Surgical Intervention and the NETest (NCT03012789) | Wren Laboratories LLC | 2017-05-15 |
| DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor (NCT03143946) | University Medical Center Groningen | 2016-12-15 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Optimal Feeding for NET Patients (NCT02481804) | University Medical Center Groningen | 2015-05-01 |
| Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor (NCT02472678) | University Medical Center Groningen | 2015-05-01 |
| RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide (NCT02270567) | Wren Laboratories LLC | 2015-02-01 |
| GA-68 DOTA-TOC of Somatostatin Positive Malignancies (NCT02177773) | University of California, San Francisco | 2014-06-23 |
| Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study (NCT02147106) | University Medical Center Groningen | 2014-05-01 |
| Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors (NCT02092714) | Fox Chase Cancer Center | 2013-10-16 |
| Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study (NCT01849523) | University Medical Center Groningen | 2013-10-01 |
| Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT (NCT01869725) | Sue O'Dorisio | 2013-04-01 |
| A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors (NCT01476592) | University of Wisconsin, Madison | 2011-12-01 |
| Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours (NCT01448083) | Nuclear Medicine Consultants, Inc. | 2011-10-01 |
| AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors (NCT01024387) | Dana-Farber Cancer Institute | 2010-03-01 |
| Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors (NCT00942682) | Dana-Farber Cancer Institute | 2009-07-01 |
| 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) (NCT01048086) | University of Iowa | 2009-06-01 |
| Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors (NCT00569738) | Hadassah Medical Organization | 2008-12-01 |
| Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors (NCT00804336) | Dana-Farber Cancer Institute | 2008-10-01 |
| Gastrointestinal Motility in Patients With Neuroendocrine Tumors (NCT00789841) | University of Aarhus | 2008-09-01 |
| Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization (NCT00434109) | H. Lee Moffitt Cancer Center and Research Institute | 2006-11-01 |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy (NCT00363051) | Novartis Pharmaceuticals | 2006-06-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors (NCT00227617) | University of California, San Francisco | 2005-06-08 |
| Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00131911) | National Cancer Institute (NCI) | 2005-06-01 |
| Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors (NCT00165230) | Dana-Farber Cancer Institute | 2002-05-01 |